Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 00:00 source : Www.clinuvel.com save search
News Kommuniqué IV
Published: 2023-10-23 (Crawled : 00:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CEO letter to shareholders
Published: 2023-09-18 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: -0.24%
H: 0.0%
C: -2.72%
ceo
Afamelanotide Significantly Reduces DNA Damage in a Healthy Population
Published: 2023-08-14 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 1.03%
H: 0.0%
C: 0.0%
dna
Technical Note: DNA Damage and Repair
Published: 2023-08-14 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 1.03%
H: 0.0%
C: 0.0%
dna
CLINUVEL secures IP for melanocortins to treat central nervous system disorders
Published: 2023-07-13 (Crawled : 00:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: 3.57%
H: 0.0%
C: 0.0%
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 2.2%
H: 0.0%
C: -0.35%
treat system
Commercial Update SCENESSE®
Published: 2023-03-08 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: -1.18%
H: 1.5%
C: -0.03%
scenesse commercial update
CLINUVEL launches CYACÊLLE, Next Generation Solar Care
Published: 2023-02-28 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 3.53%
H: 0.5%
C: -0.19%
solar care
Proposed issue of Securities
Published: 2023-02-27 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: -5.85%
H: 0.0%
C: -1.0%
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population
Published: 2023-02-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 0.64%
H: 2.18%
C: 0.8%
skin
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population – Technical Note
Published: 2023-02-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 0.64%
H: 2.18%
C: 0.8%
skin
NEURACTHEL® manufacturing processes advance
Published: 2023-01-22 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 0.27%
H: 4.17%
C: 1.24%
neuracthel
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum
Published: 2023-01-15 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
dna
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum – Technical Note
Published: 2023-01-15 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
dna
Media release: CLINUVEL Trial Results Show Drug Reduces DNA Damage
Published: 2023-01-15 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
drug media dna trial results show
CLINUVEL’s Sydney Soirée 2022
Published: 2022-10-13 (Crawled : 00:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 6.31%
H: 0.0%
C: 0.0%
CLINUVEL appoints new Non-Executive Director
Published: 2022-04-03 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: -4.2%
H: 5.85%
C: 4.92%
CLINUVEL Extends Employment Agreement With CEO
Published: 2022-03-31 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: -1.15%
H: 0.0%
C: -1.6%
ceo
Change of Director’s Interest Notice
Published: 2022-03-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: -2.3%
H: 0.7%
C: 0.67%
Appendix 4C & Activity Report
Published: 2022-01-30 (Crawled : 00:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: 3.1%
H: 0.3%
C: -0.12%
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
|
| O: 3.57%
H: 0.77%
C: 0.22%
report
CLINUVEL completes enrolment in world-first stroke study
Published: 2022-01-16 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 6.16% 31.84% 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
stroke enroll
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.